Varicella vaccination in pediatric kidney transplant candidates.
Existing studies support the use of varicella vaccine in a two-dose regimen in patients with renal disease prior to transplantation. Levels of anti-varicella zoster virus antibody should be monitored on a regular basis after immunization, and where a loss of a previously protective antibody titer occurs, a third booster dose should be considered pretransplant. Further data need to be collected regarding the use of the vaccine in seronegative patients who have already undergone transplantation.
Furth
Susan L
SL
Department of Pediatrics, the Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. sfurth@jhmi.edu
Fivush
Barbara A
BA
D002644:Chickenpox / Q000276:immunology / Q000517:prevention & control*; D019433:Chickenpox Vaccine / Q000008:administration & dosage* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000379:methods; D008297:Male; D011300:Preoperative Care; D011322:Primary Prevention / Q000379:methods*; D012680:Sensitivity and Specificity; D014181:Transplantation Immunology / Q000502:physiology*; D014611:Vaccination / Q000592:standards / Q000639:trends
D019433:Chickenpox Vaccine